Skip to main content
SpringerLink
Log in

Captopril influences an early process of atherosclerosis using an in vitro model

  • Conference paper
Forschung ohne Tierversuche 2000

Part of the book series: Ersatz- und Ergänzungsmethoden zu Tierversuchen ((TIERVERSUCHE))

  • 319 Accesses

Abstract

Monocyte interactions with endothelial cells are playing an important role during the early process of atherosclerosis. The angiotensin Converting enzyme (ACE) inhibitor Captopril has been shown to influence platelet adhesion to endothelial cells. The aim of the current study was to investigate if Captopril can also influence leukocyte migration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Authors
  1. R. Hofbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Kos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Muellner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Gmeiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Speiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Kapiotis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. zet — Zentrum für Ersatz- und Ergänzungsmethoden zu Tierversuchen, A-Linz, Austria

    Harald Schöffl

  2. ZEBET — Zentralstelle zur Erfassung und Bewertung von Ersatz- und Ergänzungsmethoden zum, Tierversuch im BgVV — Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin, D-Berlin, Germany

    Horst Spielmann

  3. Institut für Medizinische Physik und Biophysik, Karl-Franzens-Universität, A-Graz, Austria

    Helmut A. Tritthart

  4. FFVFF — Fonds für versuchstierfreie Forschung, CH-Zürich, Switzerland

    Franz P. Gruber

  5. zet — Zentrum für Ersatz- und Ergänzungsmethoden zu Tierversuchen, A-Wien, Germany

    Helmut Appl

  6. Institut für österreichisches und internationales Handels- und Wirtschaftsrecht, Universität Salzburg, A-Salzburg, Austria

    Friedrich Harrer

  7. Institut für Physiologie und Balneologie, Universität Innsbruck, A-Innsbruck, Austria

    Walter Pfaller

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag/Wien

About this paper

Cite this paper

Hofbauer, R. et al. (2000). Captopril influences an early process of atherosclerosis using an in vitro model. In: Schöffl, H., et al. Forschung ohne Tierversuche 2000. Ersatz- und Ergänzungsmethoden zu Tierversuchen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6760-1_83

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6760-1_83

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83046-8

  • Online ISBN: 978-3-7091-6760-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation